AmerisourceBergen (ABC), one of the nation’s largest pharmaceutical wholesalers, is eliminating 225 jobs — roughly 15 percent of the entire workforce — at Pharmedium Services, its troubled compounding unit that has concerned regulators and rattled investors.

The cuts are being made specifically at a beleaguered Memphis plant, where operations were suspended nearly a year ago and product recalls were issued due to sterile manufacturing issues, all of which followed an inspection by the Food and Drug Administration.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The reason why I only use one extremely careful, and well know to the communities of compounding pharmacies, for their ethics and integrity of themselves and the products that they use for the compound process. A clean and compassionate place for anyone who has to have a compound prescription. The one that I use, is the only one that I ever would want for my own medications. I consider myself to be a very fortunate individual to have this pharmacy for myself.

  • Perhaps they need to re-brand this unit – “Pharminimum.” (Another source of ‘adulterated drugs’ that FDA cannot stop ‘at the waters edge.’)

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy